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Abstract 
CHD6 is a chromatin remodeling protein 
characterized to play a role in transcriptional 
repression of genes and viruses.  
It occurs in a nuclear location as a component of a 
larger complex which associates with RNA Pol II. 
Mutations in CHD6 are associated with motor 
coordination defects, and development of cancers 
following substitutions and translocations. 
Keywords 
Chromodomain Helicase DNA Binding protein 6 - 
CHD6 
Identity 
Other names: CHD-6, CHD5, RIGB 
HGNC (Hugo): CHD6 
Location: 20q12 
DNA/RNA 
Description 
The CHD6 gene is encoded by 38 exons spanning 
216394 bp. In addition to the full length transcript 
there are 5 predicted but not specifically reported 
splice variants of human CHD6. The CHD6 cDNA 
sequence spans 10826 bp, with a 5' untranslated 
region of 179 bp, an open reading frame of 8148 bp, 
and a 3' untranslated region of 2492 bp (NCBI: 
NM_032221.4) (Schuster and Stöger, 2002). 
Transcription 
CHD6 mRNA is found in all tissues examined, with 
the greatest levels found on reproductive tissues, 
digestive tissues, brain, bone marrow, muscle, lymph 
node, and spleen (EMBL-EBI: E-MTAB-1733). 
Pseudogene 
CHD6 in humans has no identified pseudogene. 
CHD6 is a located on chromosome 20q12 in humans. The transcript contains 38 exons. Exons are indicated relative to size in 
red, 5' and 3' untranslated regions are indicated in blue. Exon number is indicated below graphic. Position of the gene on the 
chromosome and the location of the centromere and q terminus are indicated (adapted from the NCBI graphics viewer). 
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CHD6 protein functional domains. Chromodomains are highlighted in purple, the highly conserved SNF2-like ATPase region is 
indicated in light blue, and the DNA binding domain (green oval) contains BRK binding sights, indicated by the red diamonds. 
 
 
Protein 
Description 
CHD6 is a member of the very homologous SNF2 
superfamily of chromatin remodeling enzymes 
(SWI2/SNF2, ISWI, and CHD enzyme families). 
These enzymes all contain a highly conserved 
HELICc DEAD-like helicase/ATPase with seven 
conserved catalytic regions (Brown et al., 2007; 
Marfella and Imbalzano, 2007).  
The nine CHD family members all contain n-
terminal chromodomains and the HELICc 
ATPase/helicase region, and are split into three 
subfamilies, distinguished by the additional 
functional domains in each (Marfella and Imbalzano, 
2007; Stanley et al., 2013). CHD6 contains a DNA 
binding region in its c-terminal region with 
conserved BRK domains (Schuster and Stöger, 
2002).  
CHD6 is localized to the nucleus and is found in 
large multi-protein chromatin remodeling 
complexes, including the Nrf2 transcription factor 
(Nioi et al., 2005).  
Additionally, CHD6 is a DNA dependent ATPase. 
CHD6 protein is expected to function as a 
transcriptional repressor and it has been shown to be 
interact with RNA Pol II proteins (Lutz et al., 2006) 
and to be involved in the cellular repression of viral 
replication (Fertey et al., 2010; Alfonso et al., 2011; 
Alfonso et al., 2013). Size: 2715 amino acids; 
305412 Da. 
Expression 
CHD6 protein is expressed in all tissues assayed 
including, monocytes, lymphocytes, kidney, liver, 
lung, colon, bone, brain, ovary, prostate, cervix, and 
breast (Data sourced from MOPED, PaxDb, and 
MaxQB, by GeneCards.org Version: 3.12.142 28 
July 2014). Low dose radiation induces CHD6 
expression in the lymphoblastoid cell line AHH-1, 
and both A549 and HeLa cell lines (Wang et al., 
2006). 
Localisation 
Nuclear. 
Function 
Chromatin remodeling, transcription co-factor 
binding, suppression of gene expression. 
Homology 
CHD6 has homologues in chimpanzee, Rhesus 
monkey, dog, cow, mouse, rat, chicken, zebrafish, 
and frog. 
Mutations 
Note 
There have been no reports of naturally occurring 
homozygous inactivation of CHD6. Mutations have 
been identified in several types of cancer, however, 
no nonsense or frameshift mutations exclusive to 
CHD6 have been associated with cancer to date 
(Cosmic database). Haploinsufficiency in CHD6 has 
been reported in miscarriage and mental retardation 
(Yamada et al., 2010) and mutation of the ATPase 
region in mice resulted in an ataxia phenotype 
(Lathrop et al., 2010). 
Implicated in 
Acute myeloid leukemia (AML) 
Note 
The presence of a fusion gene between LMBRD1 
and CHD6 was identified in a case report of AML. 
Development of AML from an acute MDS/MPD 
diagnosis occurred over two years. FISH mapping of 
increasingly specific bacterial artificial 
chromosomes was used to identify the breakpoints of 
this AML between exons 1 and 2 of CHD6 (Douet-
Guilbert et al., 2014). 
Hybrid/Mutated gene 
Fusion gene between LMBRD1-CHD6 
(6;20)(q13;q12). 
Myeloproliferative disorder (MPD)/ 
myelodysplastic syndrome (MDS) 
Note 
Chromosome 20q12 is a common breakpoint 
associated with the development of MPD/MDS, 
however with the increased specificity of 
chromosome mapping techniques the frequency of 
the CHD6 gene specifically mutated in this disease 
is still being more precisely determined (Huh et al., 
2010; Padhi et al., 2013). 
Colorectal cancer 
Note 
CHD6 has been implicated in two studies using  
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genome wide analysis of colorectal cancer cell lines. 
A comparison between tumor cell lines and primary 
tumors found that cell lines accurately reflect the 
diversity of mutations associated with primary tumor 
samples (Mouradov et al., 2014). Additionally this 
study determined that mutations in chromatin state 
regulators (including CHD6) are commonly found in 
colorectal cancer.  
Further research examined the copy number 
variation (CNV) found between colorectal cancer 
and normal tissue samples (Ali Hassan et al., 2014). 
Significant alterations in CNV were observed on 
chromosomes 8, 13, and 20.  
The gain of copies on chromosome 20q12 was the 
most significant finding, occurring in 45% of tumor 
tissues examined, specifically over a 2445 kbp 
region containing eight genes that include PTPRT, 
TOP1, and CHD6 (Ali Hassan et al., 2014). 
Bladder transitional cell carcinoma 
(TCC) 
Note 
Analysis of multiple TCC tissues identified a group 
of chromatin remodeling enzyme genes with 
mutations occurring in 59% of patients.  
CHD6 was found mutated in multiple lines 
examined, however, only in one line was the 
mutation exclusive to CHD6. Linked mutation of 
CHD6 and two other genes, ANK2 or LRP2 was 
found to correlate with the development of TCC (Gui 
et al., 2011). 
Various cancers (malignant 
melanoma, glioma, cervical cancer, 
lung, urinary tract, large intestine, 
and others) 
Note 
Whole genome analysis of tumor tissues and culture 
cell lines have identified point mutations within 
CHD6.  
These mutations and copy number variations occur 
at low frequencies and are often not likely 
pathologically associated with the development of 
the cancers.  
The alterations have been found in the following 
tissues: malignant melanoma (5 substitution 
mutations: NCBI ClinVar Database, last update 04-
24-2014), multiple tumor tissue sources identifying 
283 mutations in haematopoietic and lymphoid 
(0.23% of tested samples), central nervous system 
(0.74%), cervix (14.3%), endometrium (8.5%), 
prostate, urinary tract (14.3%), ovary, breast, lung 
(7.0%), stomach (6.4%), skin, kidney, large intestine 
(10.6%), liver, oesophagus, and pancreas. The bulk 
of mutations are composed of nonsense substitution: 
7.42%, missense substitution: 68.90%, synonymous 
substitution: 27.92%, deletion frameshift: 2.12% 
(COSMIC Database, v69). This database further 
identified copynumber variants in the following 
tissues; haematopoietic and lymphoid, central 
nervous system, breast, lung, endometrium, kidney, 
large intestine, lung, ovary, and pancreas tumor 
tissues, with gain of copy number, more common 
than loss of copy number (COSMIC Database, v69). 
Influenza/human papillomavirus 
Note 
CHD6 has been identified as playing a role in the 
repression of influenza A infections. It associates 
with viral ribonuclear proteins in infected cells 
(Alfonso et al., 2011). Loss of CHD6 by siRNA 
silencing results in an increased viral replication, 
while in lungs of infected mice, CHD6 is degraded 
upon infection and exposure to the three subunits of 
the viral polymerase (Alfonso et al., 2013). Recent 
reports also indicate that CHD6 interacts with human 
papillomavirus proteins, binding and repressing the 
expression of oncogenes (Fertey et al., 2010). This 
suggests that CHD6 plays a role in gene suppression 
and is important in the response to viral infection. 
Ataxia 
Note 
Mutations in CHD6 that affect functional subunits 
are linked to the development of an ataxic 
phenotype. The deletion of the ATPase region of 
CHD6 in a mouse model resulted in deficiencies in 
coordinated movement, which did not progress over 
time (Lathrop et al., 2010). Additionally, a recent 
study utilizing genome wide analysis of genes 
associate with coordination defects in ADHD 
identified CHD6 as one of the most relevant target 
genes (Fliers et al., 2012). 
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